(Q43824330)

27 November 2017

Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients (English)

1 reference

27 November 2017

1 reference

1 reference

1

J L Blum

1 reference

27 November 2017

V Dieras

2

1 reference

27 November 2017

P M Lo Russo

3

1 reference

27 November 2017

J Horton

4

1 reference

27 November 2017

O Rutman

5

1 reference

27 November 2017

A Buzdar

6

1 reference

27 November 2017

B Osterwalder

7

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

27 November 2017

1 reference

27 November 2017

92

1 reference

27 November 2017

7

1 reference

27 November 2017

1759-1768

1 reference

Vinorelbine-induced neurotoxicity in patients with advanced breast cancer pretreated with paclitaxel--a phase II study

27 November 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1759%3A%3AAID-CNCR1691%3E3.0.CO%3B2-A

Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1759%3A%3AAID-CNCR1691%3E3.0.CO%3B2-A

Patient preferences for oral versus intravenous palliative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1759%3A%3AAID-CNCR1691%3E3.0.CO%3B2-A

A study of quality of life in cancer patients receiving palliative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1759%3A%3AAID-CNCR1691%3E3.0.CO%3B2-A

Clinical pharmacokinetics of capecitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1759%3A%3AAID-CNCR1691%3E3.0.CO%3B2-A

Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1759%3A%3AAID-CNCR1691%3E3.0.CO%3B2-A

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1759%3A%3AAID-CNCR1691%3E3.0.CO%3B2-A

Phase I and pharmacokinetic study of the oral fluoropyrimidine capecitabine in combination with paclitaxel in patients with advanced solid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1759%3A%3AAID-CNCR1691%3E3.0.CO%3B2-A

A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1759%3A%3AAID-CNCR1691%3E3.0.CO%3B2-A

Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1759%3A%3AAID-CNCR1691%3E3.0.CO%3B2-A

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1759%3A%3AAID-CNCR1691%3E3.0.CO%3B2-A

Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1759%3A%3AAID-CNCR1691%3E3.0.CO%3B2-A

A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1759%3A%3AAID-CNCR1691%3E3.0.CO%3B2-A

Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011001%2992%3A7%3C1759%3A%3AAID-CNCR1691%3E3.0.CO%3B2-A

10.1002/1097-0142(20011001)92:7<1759::AID-CNCR1691>3.0.CO;2-A

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference